At Aelius Biotech we understand the barriers to developing orally delivered products because we understand the barriers of the gastrointestinal tract.
We develop and use world leading in vitro gastrointestinal models that integrate the digestive, mucus and epithelial barriers. With these models we help you to de-risk and accelerate the development of the next generation of orally delivered products.
